Abstract Hyperbaric oxygen therapy (HBOT) is used for a number of applications, including the treatment of diabetic foot ulcers and CO poisoning. However, we and others have shown that HBOT can mobilize cellular antioxidant defenses, suggesting that it may also be useful under circumstances in which tissue protection from oxidative damage is desired. To test the protective properties of hyperbaric oxygen (HBO) on a tissue level, we evaluated the ability of a preconditioning treatment regimen to protect cutaneous tissue from UV-A-induced oxidative damage. Three groups of hairless SKH1-E mice were exposed to UV-A 3 days per week for 22 weeks, with two of these groups receiving an HBO pretreatment either two or four times per week. UV-A exposure increased apoptosis and proliferation of the skin tissue, indicating elevated levels of epithelial damage and repair. Pretreatment with HBO significantly reduced UV-Ainduced apoptosis and proliferation. A morphometric analysis of microscopic tissue folds also showed a significant increase in skin creasing following UV-A exposure, which was prevented by HBO pretreatment. Likewise, skin elasticity was found to be greatest in the group treated with HBO four times per week. The effects of HBO were also apparent systemically as reductions in caspase-3 activity and expression were observed in the liver. Our findings support a protective function of HBO pretreatment from a direct oxidative challenge of UV-A to skin tissue. Similar protection of other tissues may likewise be achievable.
Introduction
Hyperbaric oxygen therapy (HBOT) is a method of treatment in which patients inspire 100 % oxygen at a pressure greater than 1 atm (Londahl 2012) . At present, HBOT has been approved for use in a number of clinical settings, including the treatment of carbon monoxide poisoning, air/ gas embolisms, and chronic wounds (Gill and Bell 2004) . It has also been shown to significantly enhance the healing of diabetic foot ulcers (Abidia et al. 2003; Kessler et al. 2003; Duzgun et al. 2008 ), improve quality of life (Londahl et al. 2011) , and decrease the need for limb amputations in these patients (Faglia et al. 1996; Thackham et al. 2008; Bishop and Mudge 2012) . It is currently known that HBOT increases the partial pressure of oxygen in hypoxic tissue (Al-Waili and Butler 2006; Babchin et al. 2011 ) and attenuates the inflammatory response by interfering with cytokine production and activity (Alex et al. 2005; Daniel et al. 2011; Lin et al. 2012) . It has also been reported that HBOT increases the production of reactive oxygen species (ROS) within the tissue (Matsunami et al. 2011; Simsek et al. 2011) , thereby mobilizing cellular antioxidant responses (Matsunami et al. 2009; Godman et al. 2010b; He et al. 2011) . Accordingly, hyperbaric oxygen (HBO) has been acknowledged as an effective preconditioning agent under circumstances in which protection from oxidative damage is desired, such as in rat models of myocardial infarction (Han et al. 2008; Sun et al. 2011 ) and cerebral ischemia-reperfusion injury Cheng et al. 2011) .
We previously reported that HBOT efficiently induces the expression of a number of cytoprotective genes in human microvascular endothelial cells (HMEC-1), including molecular chaperones and Nrf2-regulated antioxidant genes (Godman et al. 2010a, b) . These changes in gene expression conferred significant protection against cell death by exposures to both hyperthermia and the oxidizing agent t-butylhydroperoxide in vitro. The antioxidant genes activated by HBOT include heme oxygenase-1 and metallothionein, which have been reported to protect cells from oxidative stress-induced damage (Bell and Vallee 2009; Xue et al. 2009; Verma et al. 2010; Hou et al. 2012) . The ability of HBOT to activate the expression of antioxidant genes has also been reported for a number of other cell and tissue types (Shiraishi et al. 1983; Padgaonkar et al. 1997; Dennog et al. 1999; Rothfuss et al. 2001) . However, little is known about the functional consequences of these gene expression changes and whether HBOT can indeed protect tissues from oxidative damage. We were therefore interested in determining whether HBO preconditioning can protect cutaneous tissue from UV-A radiation, a known inducer of oxidative stress (Phillipson et al. 2002; Marrot et al. 2005; Hseu et al. 2012; Svobodová et al. 2012) . UV-A penetrates the dermalepidermal junction and hypodermis of the skin and imparts tissue damage via the generation of ROS. These molecules can oxidize proteins and lipids and react with DNA to cause single-strand breaks and base modifications (Svobodova et al. 2011) . This process imparts a number of molecular changes to skin tissue, including the increased turnover of keratinocytes (El-Abaseri et al. 2006 ) and an overwhelming of cellular protective responses, ultimately leading to increased levels of cell death (Gentile et al. 2003; He et al. 2005; Pustisek and Situm 2011) . If HBO does indeed have protective properties as a preconditioning agent, we reasoned that it should be clearly manifested by the suppression of these markers of UV-A-induced skin damage. These studies would have direct implications for the protection of the skin from UV-A radiation (Svobodova et al. 2011; Poljsak and Dahmane 2012) and further demonstrate the utility of HBO for tissue protection from chronic, repetitive oxidative stress.
In these studies, three groups of hairless SKH1-E mice were exposed to an escalating UV-A dose for 22 weeks (Benavides et al. 2009 ). Two groups of animals were additionally subjected to HBO preconditioning either two or four times per week under conditions that approximated clinical settings (Gill and Bell 2004; Londahl 2012) . Consistent with a preconditioning model, mice exposed to HBO showed a reduced level of radiation-induced cell turnover and skin creasing. Interestingly, changes in gene expression consistent with cellular protection were also observed in the liver. Our findings demonstrate that HBO can protect skin tissue from UV-A-induced oxidative damage. Due to the systemic nature of HBO treatment, its protective effects may also extend to tissues that are not directly exposed to the stressor.
Materials and methods

Animal model
Cutaneous tissue is constantly and directly exposed to solar light, the primary environmental source of UV-A radiation (Svobodova et al. 2011; Poljsak and Dahmane 2012) , and is easily accessible for experimental manipulation and noninvasive measurements. The hairless SKH1-E mouse has been used extensively in prior studies of skin physiology (Panteleyev et al. 1998; Benavides et al. 2009 ) and was therefore selected for these experiments. These immunocompetent, unpigmented animals permit ready exposure to UV-A radiation as well as direct visualization of skin response (Benavides et al. 2009 ).
Experimental design
Thirty-seven SKH1-E mice obtained from Charles River Laboratories, International, Inc. (Wilmington, MA, USA) were used in these experiments. All mice were housed and treated in accordance with protocols approved by the Institutional Animal Care and Use Committee at the University of Connecticut. Mice were randomly assigned to one of four groups (n08-10 per group): UV-A+2× HBO (100 % O 2 , 2.4 atm, 1 h, twice per week); UV-A+4× HBO (100 % O 2 , 2.4 atm, 1 h, 4 days per week); UV-A only; or control (mice were handled, but no UV-A exposure nor HBO pretreatment was conducted). Animals undergoing UV-A exposure were subjected to a whole-body irradiation three times per week using 15-W, F15T8/BLB black light bulbs (General Electric, Fairfield, CT, USA; Fig. 1a ). An escalating UV-A dose over a period of 22 consecutive weeks was employed, starting at 90 mJ/cm 2 and increasing 10 % per week until a dose of 175 mJ/cm 2 was reached. HBO preconditioning treatments were administered using an OxyCure 3000 hyperbaric incubator (OxyHeal Health Group, National City, CA, USA). Intermittent, normobaric air breaks may be included in HBOT treatment regimens in order to reduce the risk of seizures resulting from CNS oxygen toxicity (Chavko and McCarron 2006) . However, at the standard clinical dose of 2.4 atm, this response is exceedingly rare and has been shown to occur at a rate of only 0.0024 % (Yildiz et al. 2004) . Because oxygen toxicity to cells and tissues was not a significant issue in our study, and the inclusion of air breaks would have substantially complicated our treatment protocol, this was not included. However, all animals were monitored during and after treatment, and no indications of distress or seizure were observed. Animals were also weighed on a weekly basis in order to assess any impact of treatment on the growth rate and overall health. Following the treatment period, mice were euthanized and their skin and liver tissues removed. Tissue samples were fixed in 4 % paraformaldehyde and then processed for sectioning and histological analysis. Others were snap-frozen and used for biochemical assays.
Preparation of cytosolic liver extracts
To prepare cytosolic liver extracts, sections of tissue weighing 28.5±1.5 mg were obtained from each animal. Each sample was added to 400 μL of buffer A (10 mM HEPES, pH 7.9, 10 mM KCl, 0.1 mM EDTA, 2 mM MgCl 2 , 15 mM sucrose) containing 0.1 % Nonidet-P40 (NP40) cell lysis buffer. Tissue was lysed via homogenization and centrifuged at 10,000×g for 5 min. The supernatant (20 μL) was removed from each sample and used to create pools representative of all treatment groups. Extracts were stored at −80°C.
Immunohistochemistry
Skin and liver tissues were dehydrated, formalin-fixed, and embedded in paraffin according to standard procedures, and 10-μm-thick sections were cut and mounted on glass slides. The slides were de-paraffinized and rehydrated according to standard protocols and then heated in 10 mM citrate buffer (pH 6.0) for 20 min for epitope retrieval. The skin tissue was blocked at room temperature for 30 min using 5 % serum (in phosphate-buffered saline) and incubated for 1 h with diluted primary antibodies (1:100 in 5 % serum) against proliferating cell nuclear antigen (PCNA; rabbit polyclonal, SC-7907, Santa Cruz Biotechnology, Santa Cruz, CA, USA) or cleaved/active caspase-3 (rabbit polyclonal, no. 9662S, Cell Signaling Technologies, Beverly, MA, USA). The liver tissue was similarly blocked and incubated with diluted primary antibodies against cleaved caspase-3 only. CY3-conjugated secondary antibodies (goat polyclonal, no. 111-165-144, Jackson ImmunoResearch, West Grove, PA, USA) diluted 1:100 in 5 % serum were selected for a 30-min incubation. A DAPI counterstain was performed to facilitate the visualization of tissue nuclei, and coverslips were mounted on slides for imaging.
TUNEL staining
Skin and liver tissues were prepared and mounted on glass slides as described previously. Slides were de-paraffinized and rehydrated according to standard protocols and heated in 10 mM citrate buffer (pH 6.0) for 20 min. An in situ Cell Death Detection Kit (no. 11684795910, Roche Applied Science, Indianapolis, IN, USA) was employed to stain for DNA fragmentation (apoptosis) according to the manufacturer's instructions, and coverslips were mounted on slides for imaging. The data were quantified by determining the number of terminal deoxynucleotidyl transferase dUTP nick end-labeling (TUNEL)-positive cells per length of epidermis.
Since some normal-appearing cells were weakly labeled, only cells showing intense staining and an apoptotic morphology (e.g., "rounding-up") were counted as positive.
Analysis of skin micro-creasing
Histological samples were utilized to quantify microscopic folds within cutaneous tissue. Tissue sections were imaged, and measurements of the depths of individual "microcreases" were made using an equal number of images and animals per treatment group (n08). Individual measurements within each group were summed to generate a total micro-creasing value.
Skin elasticity
The skin elasticity of animals was assessed using a Reviscometer RVM 600 probe (C-K Electronic, Köln, Germany). This device uses two parallel sensors to measure the propagation of ultrasonic waves through the tissue and is sensitive to the density and orientation of collagen fibers and the moisture content of the tissue. Wave propagation (resonance running time, RRT) is expressed in arbitrary units (Uhoda and Piérard 2003; Ruvolo et al. 2007; Sommerfeld 2007 ).
Caspase-3 activity
Fifty microliters of the supernatant from individual cytosolic liver extracts was diluted to 0.5 μg/μL and added to 50 μL of 2× reaction mixture (20 mM PIPES, pH 7.4, 4 mM EDTA, 0.2 % CHAPS, 10 mM DTT) containing 0.2 mM of the fluorogenic substrate acetyl-Asp-Glu-Val-Asp-7-amino-4-methylcoumarin (DEVD-AMC; Enzo Life Sciences, Farmington, NY, USA). The reaction was carried out on a 96-well plate, and the fluorescence was measured using a microplate reader (excitation/emission, 360/460) at the start of the reaction and after 15 min. Protein concentrations were determined using the BioRad Protein Assay reagent according to the manufacturer's instructions (BioRad, Hercules, CA, USA). The enzyme activity was quantified by dividing the change in fluorescence after 15 min by the total amount of protein in each reaction mixture (Kuratnik et al. 2012) .
Results
Experimental design
To determine the effect of HBO preconditioning on the skin tissue, hairless SKH1-E mice were sorted randomly into four groups (shown schematically in Fig. 1a ). Three groups of animals were exposed to UV-A three times per week, with two of these groups receiving an HBO pretreatment either two or four times per week. An unexposed and untreated control group was run in parallel. The HBO dose was similar to that used clinically: 1 h exposure at 2.4 atm in 100 % O 2 . The safety of HBOT at this intensity is well established, with only minor side effects such as inflammation of the middle ear and reversible myopia being the most frequently reported (Heyneman and Lawless-Liday 2002; Tiaka et al. 2012 ). Accordingly, no major deviation in growth curves was observed for the groups receiving HBO pretreatment (Fig. 1b) .
Effects of HBO preconditioning on cell turnover in the skin
To determine the effect of UV-A and HBO preconditioning on keratinocyte turnover, cutaneous tissue was stained for the cell proliferation marker PCNA (von Neubeck et al. 2012) , and a proliferation index was derived by calculating the ratio of PCNA-positive nuclei to the total nuclei within the tissue (Kuratnik et al. 2012; Rigatti et al. 2012) . Figure  2a , b shows representative images and the quantified data, respectively. The PCNA staining index in the group treated only with UV-A was significantly higher than that of the control group. HBO pretreatment, either two or four times weekly, reduced PCNA staining to the control levels, consistent with a protective effect from UV-A-induced damage.
To determine whether HBO preconditioning suppressed apoptosis associated with chronic UV-A exposure, we quantified caspase-3 activation in the four groups. Figure 3a showed a higher staining index than the control animals. Likewise, both groups pretreated with HBO had significantly lower levels of active caspase-3 staining in comparison to the UV-A-exposed animals. A TUNEL stain for DNA fragmentation ( Fig. 4a ) generated similar results. The labeling index (Fig. 4b ) was significantly higher in the UV-A-only group relative to the control or HBO-preconditioned animals.
HBO preconditioning and structural changes in the skin
To assess the impact of experimental treatment on the skin structure, we measured the total depth of skin "micro-creases"
(microscopic tissue folds) per animal using hematoxylin and eosin-stained sections. The red bars in Fig. 5a show how the micro-creasing measurements were obtained; an equal number of animals and images within each treatment group were analyzed. The degree of creasing was significantly higher in the animals treated with UV-A alone, relative to the control or those receiving HBO preconditioning (Fig. 5b) . This is consistent with an HBO-induced protection of the tissue. Using a Reviscometer 600, we determined the ability of HBO preconditioning to prevent the loss of skin elasticity incurred from chronic UV-A exposure. Although UV-A exposure only showed a trend to decreasing skin elasticity, animals preconditioned four times a week with HBO exhibited a statistically significant increase in elasticity relative to UV-A-treated animals (Fig. 6 ).
HBO preconditioning and liver tissue
Immunohistochemical staining for cleaved/active caspase-3 was performed on hepatic tissue sections to determine whether the livers of HBO-preconditioned animals showed signs of protection following chronic UV-A exposure (Fig. 7a, b) . UV-A-treated animals showed a trend of increasing caspase-3 staining relative to the control animals, with a significant reduction observed in animals receiving HBO pretreatment four times per week. We also assessed the activity of caspase-3 within the liver extracts using a DEVD-AMC substrate. Although UV-Atreated animals only showed a trend to increased caspase-3 activity relative to the controls, enzymatic activity was significantly decreased in animals receiving four HBO treatments per week (Fig. 7c) . No significant changes in TUNEL staining were observed (Fig. 7d) . These findings support the possibility that in addition to the skin, HBO may also be capable of exerting a protective effect on internal organs.
Discussion
Although the types of approved medical applications vary, the benefit of HBOT stems from its ability to increase tissue A. B. For example, the ability of NADPH oxidase to generate superoxide is strictly limited by the local concentration of O 2 . Increasing tissue levels of O 2 can therefore enhance wound healing by enhancing the bactericidal actions of leukocytes within hypoxic, non-healing wounds. Evidence has also been obtained that the tissue levels of NO can be enhanced by hyperbaric treatment; oxygen tension at atmospheric pressures above 2.0 can increase NO production by pulmonary endothelial cells (Buras et al. 2000) . In some instances, increased NO production has also been associated with enhanced cardioprotection in an ischemia-reperfusion model (Cabigas et al. 2006 ). In addition to increasing the activity of O 2 -utilizing enzymes, HBOT can stimulate O 2 -dependent signaling pathways, which range from MAP kinase pathways to NF-κB (Bonomo et al. 1998; Lin et al. 2002; Shyu et al. 2009; Rinaldi et al. 2011; Wang et al. 2011) . One pathway of particular interest is the Keap1/Nrf2 pathway which regulates the expression of a range of antioxidant genes that can potentially protect cells from severe oxidative stress. Employing a gene array approach, we reported that the activation of Nrf2-regulated genes, along with a number of molecular chaperones, is a dominant response of cells to HBOT (Godman et al. 2010a, b) . However, since HBOT can induce such a broad range of cell-and tissue-level effects, an important question is whether, on balance, these responses are protective. As a step toward addressing this issue, we used a hairless mouse model with UV-A as a source of oxidative stress. We find that HBO preconditioning treatments provide a protective effect to UV-A-irradiated skin, as determined by reduced epidermal turnover, cutaneous creasing, and loss of skin elasticity. Effects were also observed in the liver, which can incur some damage from UV-A exposure due to the circulation of reactive molecules (Svobodova et al. 2011) . When UV-A is used as the primary stressor, our mouse model indicates that HBO preconditioning provides a significant degree of protection from oxidative stress at the tissue level. Although this has implications regarding the protection of skin for various cosmetic purposes and pathological conditions, we propose that our data could also prove useful for understanding the mechanism of HBOmediated tissue protection.
The phenomenon known as hormesis involves a favorable biological response to sub-toxic levels of stress. Hormetic agents induce an adaptive cellular response which confers resistance to harmful doses of the same stressor (Martins et al. 2011) . We envision HBOT to be acting largely as a hormetic agent, stimulating the generation and sensing of reactive oxygen intermediates within the tissue (i.e., oxidative signaling), leading to the activation of protective responses including Nrf2 mobilization and antioxidant gene expression (Cypser and Johnson 2002; Rothfuss and Speit 2002; Godman et al. 2010a, b; Matsunami et al. 2011; Simsek et al. 2011) . The HBO-preconditioned tissue is therefore prepared to withstand the stresses of UV-A and potentially other oxidative stressors. Even though HBOT has been reported to induce a level of oxidative stress within cells and tissues, it is only rarely associated with adverse effects. HBOT may therefore generate a spectrum of ROS that efficiently induce protective pathways without inducing extensive oxidative damage to macromolecules. In support of this conclusion, we found previously (Godman et al. 2010a) only small inductions of the cytosolic chaperones involved in protein damage responses, and no mobilization of HSPA6, which is only activated in human cells that incur substantial damage. Nonetheless, as with any hormetic agent, HBO dosing schedules need to be carefully studied to allow the development of maximal tissue protection.
In addition to upregulating antioxidant gene expression, the protective effects of HBO may also derive from a number of other reported effects of high oxygen tensions in tissues. One physiological response that may contribute to tissue protection is enhanced circulation. Saglam et al. (2008) described a significant increase in the diameter of the right brachial artery in healthy subjects following 10 HBO treatments, suggestive of long-term effects on vascular physiology. Accordingly, the HBO-mediated upregulation of nitric oxide synthase has been observed in a number of cell types (Buras et al. 2000; Liu et al. 2008; Xu et al. 2009; Fig. 6 Reviscometer 600 measurements. This probe quantifies the ability of HBO preconditioning to suppress macroscopic changes in the skin arising from UV-A exposure. There is a statistically significant increase in the probe readings (RRT, expressed in arbitrary units) of mice that received HBO preconditioning four times per week relative to mice exposed to UV-A only. A higher number indicates less damaged (i.e., more elastic) skin (ANOVA and Tukey's post hoc test: *p<0.01) Lin et al. 2011; Kendall et al. 2012) . HBOT also induces the expression of angiogenin, another promoter of NO synthesis, in a chronic wound model (Kendall et al. 2012) . By stimulating NO production, HBOT triggers a vasodilatory response which increases blood flow and oxygen delivery to target tissues (Buerk 2007; Giles et al. 2012) . Although future studies are required to test the contribution of enhanced circulation to HBO preconditioning-mediated protection, this well-documented response could facilitate the efficient flow of nutrients to the tissue and the removal of reactive molecules (such as aldehydes and other breakdown products) during times of stress.
The changes in cell turnover within the skin tissue we observed following UV-A exposure likely derive in part from enhanced inflammatory signaling (Gentile et al. 2003; He et al. 2005; Rock 2009; Svobodová and Vostálová 2010; Pustisek and Situm 2011) . It is well established that UV radiation induces the production and secretion of a number of pro-inflammatory cytokines (Morita et al. 1997; Krutmann 2000; Halliday 2005 ). Interestingly, HBOT has been reported to possess anti-inflammatory effects in other scenarios (Al-Waili and Butler 2006; Thom 2009; Daniel et al. 2011) , and it can reduce the circulating levels of TNF-α, IL-1, and IL-6 (Al-Waili and Butler 2006) implicated in the cutaneous response to UV exposure (Al-Waili and Butler 2006; Thom 2009; Daniel et al. 2011) . These data suggest that HBOT may be beneficial in the management of dermatological conditions arising from pathological inflammation, such as psoriasis (Schafer 2012 ) and atopic dermatitis (Rebane et al. 2012) .
Although decreases in caspase-3 expression and activity were observed in the livers of animals pretreated with HBO four times per week, animals exposed solely to UV-A showed a trend to increasing liver caspase-3 compared to the controls. Exposure of the skin to UV-A has been shown to increase apoptosis in that tissue Boyer et al. 2012; Hseu et al. 2012; Lee et al. 2012 ), but few studies have been conducted which examined its effects on other tissues. Svobodova et al. (2011) described a number of changes in oxidative stress-related parameters in hepatic tissue following exposure to UV radiation, which were attributed in part to the circulation of reactive signaling A.
C.
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Control UV-A UV-A, 2x HBO UV-A, 4x HBO molecules generated in the skin and associated blood vessels. This finding may provide a partial explanation for the non-significant increases in liver caspase-3 we report here. Similarly, the significant skin protection afforded to mice receiving HBO four times per week may ultimately reduce the indications of liver stress observed in the irradiated animals. We expect that if the trend to increasing liver caspase-3 is indeed real, the results would obtain statistical significance if more animals were analyzed. If this is not the case, the reduced liver caspase-3 in the 4× HBOT group may instead result from a protraction of the natural caspase-3 increases that occur throughout an animal's life span (Zhang et al. 2002; Kujoth et al. 2005) . In summary, the data obtained from our mouse model support a protective function of HBO preconditioning from oxidative stress when UV-A is used as the primary stressor. We report that a preconditioning treatment regimen reduced apoptosis and proliferation in the skin and prevented detrimental structural changes such as creasing and a reduction in elasticity. The protective effects of HBO were also observed systemically because reductions in the expression and the activity of apoptotic markers were also evident in the liver. These responses may be valuable for understanding the molecular mechanisms by which HBOT confers tissue protection. They may also aid in the development of novel clinical applications for HBOT.
